CML is a myeloproliferative neoplasm characterized by the presence of the Philadelphia chromosome/translocation t(9;22)(q34;q11.2), resulting in the BCR-ABL1 fusion oncoprotein [110]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.